Attached files
file | filename |
---|---|
10-K - ANNUAL REPORT - BIOLARGO, INC. | biolargo_10k-123110.htm |
EX-31.2 - EXHIBIT 31.2 - BIOLARGO, INC. | ex31-2.htm |
EX-4.21 - EXHIBIT 4.21 - BIOLARGO, INC. | ex4-21.htm |
EX-4.20 - EXHIBIT 4.20 - BIOLARGO, INC. | ex4-20.htm |
EX-31.1 - EXHIBIT 31.1 - BIOLARGO, INC. | ex31-1.htm |
EX-4.19 - EXHIBIT 4.19 - BIOLARGO, INC. | ex4-19.htm |
EXHIBIT
32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
AND
CHIEF FINANCIAL OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
I, Dennis
P. Calvert, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual
Report of BioLargo, Inc. on Form 10-K for the fiscal year ended
December 31, 2009 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such Annual Report on Form 10-K fairly presents in all
material respects the financial condition and results of operations of BioLargo,
Inc.
Dated:
April 6, 2010
|
By:
|
/s/ Dennis P. Calvert | ||
Dennis
P. Calvert
President
and Chief Executive Officer
|
A signed
original of this written statement required by Section 906 has been
provided to BioLargo, Inc. and will be retained by BioLargo, Inc. and furnished
to the Securities and Exchange Commission or its staff upon
request.
I,
Charles K. Dargan II, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Annual Report of BioLargo, Inc. on Form 10-K for the fiscal year ended
December 31, 2009 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such Annual Report on Form 10-K fairly presents in all
material respects the financial condition and results of operations of BioLargo,
Inc.
Dated:
April 6, 2010
|
By:
|
/s/ Charles K. Dargan II | ||
Charles
K. Dargan II
Chief
Financial Officer
|
A signed
original of this written statement required by Section 906 has been
provided to BioLargo, Inc. and will be retained by BioLargo, Inc. and furnished
to the Securities and Exchange Commission or its staff upon
request.